{
    "Variants Include": [
        {
            "Gene": "PARK2",
            "variants": [
                {
                    "HGVS": "NM_004562.3:c.80A>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "A",
                        "alt": "T",
                        "position": "80"
                    },
                    "Protein Change": {
                        "ref": "K",
                        "alt": "N",
                        "position": "27"
                    },
                    "Description in input context": "K27N mutation in the Ubl domain"
                },
                {
                    "HGVS": "NM_004562.3:c.98G>A",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "98"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "Q",
                        "position": "33"
                    },
                    "Description in input context": "R33Q mutation in the Ubl domain"
                },
                {
                    "HGVS": "NM_004562.3:c.125G>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "G",
                        "alt": "C",
                        "position": "125"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "P",
                        "position": "42"
                    },
                    "Description in input context": "R42P mutation in the Ubl domain"
                },
                {
                    "HGVS": "NM_004562.3:c.137G>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "G",
                        "alt": "C",
                        "position": "137"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "46"
                    },
                    "Description in input context": "A46P mutation in the Ubl domain"
                },
                {
                    "HGVS": "NM_004562.3:c.143A>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "A",
                        "alt": "C",
                        "position": "143"
                    },
                    "Protein Change": {
                        "ref": "K",
                        "alt": "A",
                        "position": "48"
                    },
                    "Description in input context": "K48A mutation in the Ubl domain"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Autosomal Recessive Juvenile Parkinsonism",
        "MONDO": "MONDO:0007745"
    },
    "Experiment Method": [
        {
            "Assay Method": "In Vitro Autoubiquitination Assay",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Parkin Variants",
                "Description": "Recombinant WT and mutant Parkin proteins expressed in E. coli BL21 (DE3) gold and purified to homogeneity."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.80A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "K27N mutation relieves autoinhibition, resulting in increased autoubiquitination activity compared to wild-type Parkin."
                },
                {
                    "Variant": "NM_004562.3:c.98G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "R33Q mutation relieves autoinhibition, resulting in increased autoubiquitination activity compared to wild-type Parkin."
                },
                {
                    "Variant": "NM_004562.3:c.125G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "R42P mutation relieves autoinhibition, resulting in increased autoubiquitination activity compared to wild-type Parkin."
                },
                {
                    "Variant": "NM_004562.3:c.137G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A46P mutation relieves autoinhibition, resulting in increased autoubiquitination activity compared to wild-type Parkin."
                },
                {
                    "Variant": "NM_004562.3:c.143A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "K48A mutation relieves autoinhibition, resulting in increased autoubiquitination activity compared to wild-type Parkin."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Experiments were performed at least three times as mentioned in the thioester discharge assay section."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "DUblD-Parkin and pathogenic mutants were used as positive controls showing autoubiquitination activity."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Wild-type Parkin was used as a negative control showing no autoubiquitination activity under standard conditions."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "4"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "Yes",
                "Counts": "1"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "One-way ANOVA followed by Dunnett's multiple comparison post-test was used for thioester discharge assays."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "No autoubiquitination activity observed in wild-type Parkin under standard assay conditions.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Presence of high molecular weight ubiquitinated species indicating autoubiquitination activity in mutant Parkin.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cell Transfection and Ubiquitination Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "Human embryonic kidney 293 cells were transfected with Parkin variants and His-Ubiquitin constructs."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.80A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "K27N mutation shows increased ubiquitination in cells compared to wild-type Parkin, especially in the presence of MG132."
                },
                {
                    "Variant": "NM_004562.3:c.98G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "R33Q mutation shows increased ubiquitination in cells compared to wild-type Parkin, especially in the presence of MG132."
                },
                {
                    "Variant": "NM_004562.3:c.125G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "R42P mutation shows increased ubiquitination in cells compared to wild-type Parkin, especially in the presence of MG132."
                },
                {
                    "Variant": "NM_004562.3:c.137G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A46P mutation shows increased ubiquitination in cells compared to wild-type Parkin, especially in the presence of MG132."
                },
                {
                    "Variant": "NM_004562.3:c.143A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "K48A mutation shows increased ubiquitination in cells compared to wild-type Parkin, especially in the presence of MG132."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Pathogenic mutants and DUblD-Parkin showed increased ubiquitination as positive controls."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Wild-type Parkin showed lower ubiquitination levels as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "4"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Not described in the literature."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Low levels of ubiquitination similar to wild-type Parkin in the absence of proteasome inhibitor.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Increased ubiquitination levels compared to wild-type Parkin, especially in the presence of MG132.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}